SML0710

DDRI-18

≥98% (HPLC)

• 同義詞: 3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine
• 經驗公式（希爾表示法）: C₂₆H₂₀N₆
• CAS號碼: 4402-18-0
• 分子量：: 416.48
• MDL號碼: MFCD01137750
• 分類程式碼代碼: 12352200
• PubChem物質ID: 329825588
• NACRES: NA.77

屬性

• 化驗: ≥98% (HPLC)
• 形狀: powder
• 顏色: white to beige
• 溶解度: DMSO: 10 mg/mL
• 儲存溫度: 2-8°C
• SMILES 字串: NC1=CC=CC(C(N2)=NC(C=C3)=C2C=C3C4=CC5=C(C=C4)N=C(N5)C6=CC(N)=CC=C6)=C1
• InChI: 1S/C26H20N6/c27-19-5-1-3-17(11-19)25-29-21-9-7-15(13-23(21)31-25)16-8-10-22-24(14-16)32-26(30-22)18-4-2-6-20(28)12-18/h1-14H,27-28H2,(H,29,31)(H,30,32)
• InChI 密鑰: QROWVLFOWUYBIG-UHFFFAOYSA-N

描述

生化／生理作用

DDRI-18 (DNA Damage Response Inhibitor-18) inhibits nonhomologous end-joining (NHEJ) DNA repair following double strand DNA breaks induced by ionizing radiation, and enhances the effects of DNA-damaging cancer drugs like etoposide, camptothecin and doxorubicin.

DDRI-18 (DNA Damage Response Inhibitor-18) inhibits nonhomologous end-joining (NHEJ) DNA repair.

安全資訊

• 象形圖: GHS07
• 訊號詞: Warning
• 危險聲明: H315,H319,H335,H413
• 防範說明: P261 - P264 - P271 - P273 - P302 + P352 - P305 + P351 + P338
• 危險分類: Aquatic Chronic 4 - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• 標靶器官: Respiratory system
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable